Arrow Financial Corp Pfizer Inc Transaction History

Arrow Financial Corp

$1.07 Billion
Q3 2024

A detailed history of Arrow Financial Corp transactions in Pfizer Inc stock. As of the latest transaction made, Arrow Financial Corp holds 13,543 shares of PFE stock, worth $356,993. This represents 0.04% of its overall portfolio holdings.

Number of Shares

13,543

Previous 16,634 18.58%

Holding current value

$356,993

Previous $465,000 15.91%

% of portfolio

0.04%

Previous 0.05%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 01, 2024	SELL	$27.7 - $31.39 $85,620 - $97,026	-3,091 Reduced 18.58%	13,543 $391,000
Q2 2024 Jul 30, 2024	SELL	$25.26 - $29.6 $130,973 - $153,476	-5,185 Reduced 23.76%	16,634 $465,000
Q1 2024 May 21, 2024	SELL	$25.89 - $29.73 $546,822 - $627,927	-21,121 Reduced 49.19%	21,819 $605,000
Q4 2023 Feb 12, 2024	SELL	$26.13 - $33.94 $1.06 Million - $1.38 Million	-40,673 Reduced 48.64%	42,940 $1.24 Million
Q3 2023 Nov 09, 2023	SELL	$32.09 - $37.51 $757,837 - $885,836	-23,616 Reduced 22.02%	83,613 $2.77 Million
Q2 2023 Aug 09, 2023	SELL	$36.12 - $41.79 $100,485 - $116,259	-2,782 Reduced 2.53%	107,229 $3.93 Million
Q1 2023 May 03, 2023	SELL	$39.39 - $51.28 $399,060 - $519,517	-10,131 Reduced 8.43%	110,011 $4.49 Million
Q4 2022 Feb 01, 2023	SELL	$41.75 - $54.5 $33,149 - $43,273	-794 Reduced 0.66%	120,142 $6.16 Million
Q3 2022 Nov 07, 2022	SELL	$43.76 - $53.42 $56,931 - $69,499	-1,301 Reduced 1.06%	120,936 $5.29 Million
Q2 2022 Jul 25, 2022	SELL	$46.53 - $55.17 $75,611 - $89,651	-1,625 Reduced 1.31%	122,237 $6.41 Million
Q1 2022 Apr 26, 2022	SELL	$45.75 - $56.69 $53,481 - $66,270	-1,169 Reduced 0.93%	123,862 $6.41 Million
Q4 2021 Jan 28, 2022	SELL	$41.32 - $61.25 $88,466 - $131,136	-2,141 Reduced 1.68%	125,031 $7.38 Million
Q3 2021 Oct 21, 2021	SELL	$39.25 - $50.42 $40,466 - $51,983	-1,031 Reduced 0.8%	127,172 $5.47 Million
Q2 2021 Jul 21, 2021	SELL	$35.91 - $40.68 $59,287 - $67,162	-1,651 Reduced 1.27%	128,203 $5.02 Million
Q1 2021 Apr 30, 2021	BUY	$33.49 - $37.77 $42,364 - $47,779	1,265 Added 0.98%	129,854 $4.7 Million
Q4 2020 Feb 08, 2021	SELL	$33.47 - $42.56 $14,525 - $18,471	-434 Reduced 0.34%	128,589 $4.73 Million
Q3 2020 Nov 06, 2020	SELL	$31.75 - $37.25 $184,880 - $216,906	-5,823 Reduced 4.32%	129,023 $4.74 Million
Q2 2020 Jul 27, 2020	BUY	$30.12 - $36.54 $9,819 - $11,912	326 Added 0.24%	134,846 $4.41 Million
Q1 2020 Apr 21, 2020	BUY	$27.03 - $38.62 $43,166 - $61,676	1,597 Added 1.2%	134,520 $4.39 Million
Q4 2019 Feb 10, 2020	BUY	$32.92 - $37.36 $41,940 - $47,596	1,274 Added 0.97%	132,923 $5.21 Million
Q3 2019 Oct 28, 2019	BUY	$32.49 - $42.13 $4,873 - $6,319	150 Added 0.11%	131,649 $4.73 Million
Q2 2019 Jul 26, 2019	BUY	$36.98 - $41.52 $60,758 - $68,217	1,643 Added 1.27%	131,499 $5.7 Million
Q1 2019 Apr 26, 2019	BUY	$37.5 - $41.2 $4,237 - $4,655	113 Added 0.09%	129,856 $5.52 Million
Q4 2018 Feb 04, 2019	SELL	$38.47 - $43.86 $11,464 - $13,070	-298 Reduced 0.23%	129,743 $5.66 Million
Q3 2018 Oct 11, 2018	BUY	$34.47 - $41.81 $25,163 - $30,521	730 Added 0.56%	130,041 $5.73 Million
Q2 2018 Jul 30, 2018	SELL	$32.98 - $35.16 $190,855 - $203,470	-5,787 Reduced 4.28%	129,311 $4.69 Million
Q1 2018 Apr 25, 2018	SELL	$31.91 - $37.02 $143,371 - $166,330	-4,493 Reduced 3.22%	135,098 $4.79 Million
Q4 2017 Feb 05, 2018	SELL	$33.26 - $35.29 $387,977 - $411,657	-11,665 Reduced 7.71%	139,591 $5.06 Million
Q3 2017 Oct 18, 2017	BUY	$31.0 - $34.15 $4.69 Million - $5.17 Million	151,256	151,256 $5.4 Million

Others Institutions Holding PFE

# of Institutions

3,260

Shares Held

3.61B

Call Options Held

77.2M

Put Options Held

122M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $148B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Arrow Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Arrow Financial Corp with notifications on news.

Account

Arrow Financial Corp Pfizer Inc Transaction History